Actimed Therapeutics Strengthens Board with Appointment of Dr. Anders Ullman

Neutral

AI Analysis

Summary

Actimed Therapeutics announces the appointment of Dr. Anders Ullman to its Board of Directors. The company is a clinical-stage specialty pharmaceutical firm focused on cancer cachexia and muscle wasting disorder treatments.

Importance:2/10

Sentiment:

0.10

board appointmentmanagementcancer cachexiamuscle wasting

Related Companies

$IPIX

Read the original article

Published by GlobeNewswire Pharma on July 30, 2026 7:00 AM

Read Original